human recombinant interleukin 2 ( il-2 ) and tumor necrosis factor ( tnf ) were evaluated individually and in combination for their antitumor efficacy in vivo , using five s.c. murine tumors : l1210 leukemia , p815 mastocytoma , b16 melanoma , el-4 lymphoma , and the methylcholanthrene-induced sarcoma , meth a .
C0086418
human
C0021756
recombinant interleukin 2